Belgian Pharma Figures 2015, in a European Perspective

In 2015, Belgium continued to reinforce its leading position in Europe as a biopharmaceutical hub. This becomes apparent when a number of key indicators in 2015 are compared with figures of the previous year.

Belgium showed a growth well above the European average, in particular with regard to investments in R&D (+5.5%) and the employment of researchers (+2.86%). The following brochure also contains figures on Belgium's position in clinical trials, employment, exports and production.